The companies will work together to develop new cardiovascular treatments
The deals aim to accelerate drug development in oncology, neurology and immunology
Lilly is the only FDA-approved company to legally sell products containing tirzepatide
The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline
The agreement will focus on the development of bispecifics, cell therapies and cancer vaccines
Both will identify drug targets for neurodegenerative and neuromuscular diseases
The company will gain exclusive rights to develop and commercialise obexelimab
Novo gains access to Embark's lead asset targeting obesity and other cardiometabolic diseases
The transaction gives LEO access to Timber’s lead investigational candidate, TMB-001
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
The deal includes a CB1 blocker being developed to treat metabolic syndrome and its associated complications
The transaction expands the company’s gene therapy and hearing loss pipeline
The companies announced the original agreement covering two antibody-drug conjugates in April
The company will gain the first refusal to one of Poseida’s clinical stage programmes
The companies partnered last year to improve Merck's active pharmaceutical ingredient manufacturing
Astex will receive $35m upfront plus milestone payments totalling $500m per programme
Briumvi has already been approved in the US and EU for adults with relapsing forms of MS
The latest movers in pharma
The latest movers in pharma and biotech
Latest movers in pharma and biotech
Latest movers in pharma
The latest industry movers
No results were found
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...